
    
      SOVS2019-070 is a single-center, single-masked (the individual(s) performing efficacy
      measures will be masked to treatment assignment for the patient(s) they are assessing),
      vehicle-controlled, randomized, parallel group study of AZR-MD-001 ointment and AZR-MD-001
      vehicle in patients with Meibomian Gland Dysfunction (MGD) or Contact Lens Discomfort (CLD).
    
  